Kyprolis 60 mg lyophilized powder for injection Images
Generic Name: carfilzomib
This medication has been identified as Kyprolis 60 mg lyophilized powder for injection. It is supplied by Onyx Pharmaceuticals, Inc.
Kyprolis is used in the treatment of Multiple Myeloma and belongs to the drug class proteasome inhibitors. There is positive evidence of human fetal risk during pregnancy. Kyprolis 60 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Kyprolis
- Generic Name
- carfilzomib
- Strength
- 60 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Proteasome inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Onyx Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76075-0101
More about Kyprolis (carfilzomib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: proteasome inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.